This course delivers fundamental NGx concepts and addresses barriers that impede translation of research results from laboratories to people by bringing together researchers and practitioners in NGx concepts ranging from cell biology to dietetics. Designed for graduate students, health professionals and nutrition scientists from academia, agencies, and industry.
Presented by: UNC Nutrition Research Institute (NRI) and UNC Nutrition and Obesity Research Center (NORC)
Presenters are from departments of Nutrition, Genetics, Epidemiology, Psychology and Neuroscience, School of Pharmacy, and the Nutrition Research Institute at UNC-Chapel Hill; UNC Charlotte; Western Human Nutrition Research Center, USDA-ARS; Instituto Nacional de Medicina Genomica; University of Illinois; and Baylor College of Medicine USDA/ARS Children’s Nutrition Research Center.
The NRI has produced this short course annually since 2016 (with the exception of 2020 due to the pandemic) with attendees and presenters from around the world. Annual attendance is capped at 80 and past attendees have included graduate students, postdocs, faculty, industry researchers, physicians, and registered dietitians.
Registration fees include accommodations, see details below.
NGx will be held at the Embassy Suites by Hilton Charlotte Concord Golf Resort & Spa. Registration fees include the full conference and a single room in the hotel for the nights of 5/15 – 5/18, as well as continental breakfast, lunch, and dinner daily (no dinner on 5/19). Also included is transportation between event venues during the short course. Transportation to and from the conference is not included.
Robert A. Waterland, PhD is a professor in the Department of Pediatrics and the Department of Molecular & Human Genetics at Baylor College of Medicine USDA/ARS Children’s Nutrition Research Center.
On May 16 and 17, 2022, the National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS) and the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) will host a jointly sponsored virtual workshop to explore Regulatory Fitness in Rare Disease Clinical Trials.
Advances in rare diseases, particularly in the field of genetics, result in an active, highly innovative, and rapidly evolving area of science and drug development. Nonetheless, rare disease drug development represents an area of high unmet medical need. There are many challenges in rare disease drug development that are broadly recognized by the rare disease drug development community, such as:
Academic investigators, patient groups, and small or emerging pharmaceutical and biotechnology companies play a critical role in rare disease drug development and are often the sponsors for rare disease drug development, but they may lack regulatory experience. This workshop focuses on academic investigators and those looking to learn how to bridge the gap between academic investigation and the regulatory aspects of drug development.
This workshop will:
Participation in this workshop will allow attendees to improve their familiarity and understanding of Federal regulations, guidelines, and approaches for good quality rare disease clinical trials. While specific questions about applications will not be addressed, topics in general will be discussed and case studies will be presented as learning examples.
For more information about the event, please click here.
This online training session will provide an introduction to qualitative research methods. Participants will have the opportunity to ask questions and share experiences conducting qualitative research.
Topics:
Presenter:
MaryBeth Grewe, MPH, NC TraCS Community and Stakeholder Engagement Program Qualitative Research Specialist